| Oct 2 |
New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
|
| Sep 30 |
3 MedTech Stocks to Buy as Monetary Policy Eases
|
| Sep 25 |
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
| Sep 18 |
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
|
| Sep 16 |
Zacks Industry Outlook Intuitive Surgical, Masimo and Veracyte
|
| Sep 15 |
New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
|
| Sep 13 |
3 Medical Instruments Industry Stocks to Buy on genAI and M&A Boost
|
| Sep 12 |
Exploring Three High Growth Tech Stocks in the United States
|
| Sep 9 |
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now
|
| Sep 6 |
Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)
|
